Furthermore, GUCA2A was considered to be important for studies of NEC since it has been described to be involved in suppressing intestinal inflammation, [30] to be downregulated in colorectal cancer [31] and inflammatory bowel disease [32, 33], and has to our knowledge not yet been studied in NEC. This evidence concerns the gene GUCA2A and inflammatory bowel disease.